Endo to buy Auxilium for $2.6 bln, Auxilium drops QLT deal

Thu Oct 9, 2014 6:53am EDT
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

Oct 9 (Reuters) - Endo International Plc said it would buy Auxilium Pharmaceuticals Inc in a deal valued at $2.6 billion, including the repayment and assumption of debt.

Endo's offer of $33.25 per share represents a premium of about 12 percent to Auxilium's Wednesday close and is higher than Endo's previous offer of $28.10.

The deal has an equity value of $1.67 billion, according to a Reuters calculation.

As part of the deal, Auxilium terminated its proposed merger agreement with Canadian eye-drug maker QLT Inc. (Reporting by Ankur Banerjee in Bangalore; Editing by Savio D'Souza)